Latest Asx News

Prominence Energy has agreed to acquire a vast natural hydrogen and helium exploration portfolio on the Gawler Craton, backed by a $1.75 million capital raise and strategic board appointments.

The Calmer Co. International Limited has launched its Taki Mai kava tinctures on Amazon USA, marking a strategic expansion into a rapidly growing wellness segment. This move aims to capitalize on the booming US tincture market and strengthen the company’s foothold in natural relaxation products.

Trigg Minerals advances its Antimony Canyon Project with near-term pilot extraction plans and a strategic land expansion linking new mineralised zones in Utah, positioning itself to address critical US antimony supply needs.

Finder Energy has fast-tracked the development of its Kuda Tasi and Jahal oil fields in Timor-Leste through a strategic alliance with SLB, targeting initial production of up to 40,000 barrels per day. The company’s diversified portfolio and tight capital structure position it for multiple catalysts in the second half of 2025.

Jayride Group launches a new B2B SaaS platform aimed at transforming ground transportation with integrated payments, fleet management, and AI tools, promising higher margins and scalable growth.

Tryptamine Therapeutics has secured ethics approval to begin a pioneering clinical trial of TRP-8803, an IV-infused psilocin treatment, targeting adult patients with Binge Eating Disorder. The trial aims to evaluate safety and efficacy, with initial results expected by the end of 2025.

Noble Helium Limited has responded to ASX inquiries about recent unusual trading activity, attributing it to ongoing convertible note amendment negotiations but denying undisclosed information influenced the market.

Noble Helium has amended its convertible note terms with Obsidian Global, postponing share conversions until refinancing or September 2025, while issuing new shares and options as part of a strategic turnaround.

Envirosuite has secured a key regulatory green light from FIRB for its acquisition by Ideagen, moving the proposed Scheme of Arrangement closer to shareholder approval.

Universal Biosensors has requested a voluntary suspension of its shares on the ASX, pending details of a proposed capital raising. The suspension is expected to last until the end of June or until the announcement is made.

Vection Technologies has secured a $2.6 million contract to co-develop SAFE-XR, an AI-powered safety compliance platform using augmented reality and wearable tech for industrial inspections in Italy.

Amaero has completed commissioning its second advanced atomizer at its Tennessee facility, reinforcing its production capacity and reaffirming strong revenue visibility for FY2026. The company’s strategic investments position it as a key domestic supplier in the US advanced manufacturing sector.